PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

PharmaShots Weekly Snapshots (May 02-06, 2022)

PharmaShots Weekly Snapshots (May 02-06, 2022)

May 6, 2022

Orion Entered into an Agreement with Jemincare to Develop & Commercialize JMKX000623 for the Treatment of Pain

Orion Entered into an Agreement with Jemincare to Develop & Commercialize JMKX000623 for the Treatment of Pain

May 6, 2022

Coherus Terminates its License Agreement with Innovent for Byvasda (biosimilar, bevacizumab)

Coherus Terminates its License Agreement with Innovent for Byvasda (biosimilar, bevacizumab)

May 6, 2022

Amylyx Publishes Results of AMX0035 in P-II (CENTAUR) Trial for the Treatment of Amyotrophic Lateral Sclerosis in Muscle & Nerve

Amylyx Publishes Results of AMX0035 in P-II (CENTAUR) Trial for the Treatment of Amyotrophic Lateral Sclerosis in Muscle & Nerve

May 6, 2022

Palisade Bio and Newsoara’s LB1148 Receive NMPA’s Clearance to Initiate P-III Trial to Improve Bowel Function After Abdominal Surgery

Palisade Bio and Newsoara’s LB1148 Receive NMPA’s Clearance to Initiate P-III Trial to Improve Bowel Function After Abdominal Surg...

May 6, 2022

Zai Lab Partner argenx Report Results of Vyvgart (efgartigimod alfa-fcab) P-III (ADVANCE) Trial for Primary Immune Thrombocytopenia

Zai Lab Partner argenx Report Results of Vyvgart (efgartigimod alfa-fcab) P-III (ADVANCE) Trial for Primary Immune Thrombocytopeni...

May 6, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us